A pilot-scale plant was employed to validate the performance of a proposed full-scale advanced water treatment plant (AWTP) in Sydney, Australia. The primary aim of this study was to develop a chemical monitoring program that can demonstrate proper plant operation resulting in the removal of priority chemical constituents in the product water. The feed water quality to the pilot plant was tertiary-treated effluent from a wastewater treatment plant. The unit processes of the AWTP were comprised of an integrated membrane system (ultrafiltration, reverse osmosis) followed by final chlorination generating a water quality that does not present a source of human or environmental health concern. The chemical monitoring program was undertaken over 6 weeks during pilot plant operation and involved the quantitative analysis of pharmaceuticals and personal care products, steroidal hormones, industrial chemicals, pesticides, N-nitrosamines and halomethanes. The first phase consisted of baseline monitoring of target compounds to quantify influent concentrations in feed waters to the plant. This was followed by a period of validation monitoring utilising indicator chemicals and surrogate measures suitable to assess proper process performance at various stages of the AWTP. This effort was supported by challenge testing experiments to further validate removal of a series of indicator chemicals by reverse osmosis.
INTRODUCTION
To maintain river health in the Hawkesbury Nepean River system and replace more than 12 billion litres of drinking water currently released from Sydney's major water source, Warragamba Dam, Sydney Water is currently constructing an advanced water treatment plant (AWTP) that will produce up to 18 billion litres of highly treated recycled water annually.
Termed the 'Replacement Flows' project, this initiative will collect and treat municipal effluent from three major sewage treatment plants (STPs) (St Marys, Penrith and Quakers Hill) in north western Sydney.
A pilot plant simulating the processes of the proposed AWTP was constructed and operated at St Marys STP for a 3-month period. This pilot was used to refine and validate the operational parameters of the AWTP process and to define a monitoring approach for chemical and microbiological constituents for the Replacement Flows Project (RFP). A screening-level risk assessment (SLRA) undertaken for the RFP identified a number of downstream users of the Hawkesbury-Nepean river system, including the North Richmond Australian Drinking Water Guidelines to customers in North Richmond and surrounding areas (Khan et al. 2007) . The primary aim of this chemical monitoring program was therefore to validate many of the assumptions made in the SLRA and furthermore:
1. Confirm that key chemicals of potential toxicological concern (including pharmaceuticals, endocrine disrupting chemicals, and emerging disinfection by-products) in the product water are either absent or present at trace concentrations that do not present a source of human or environmental health concern.
2. Establish and validate a series of indicator chemicals and surrogate measures (bulk water parameters) that can confirm proper performance of individual AWTP unit operations.
The monitoring program developed for this project incorporates appropriate chemical indicator compounds and surrogate parameters that address validation of treatment process performance as well as operation and verification requirements described in relevant Australian Guidelines for Water Recycling (AGWR 2008).
The tailored employment of appropriate surrogates and indicator chemicals within predefined boundary conditions developed by Drewes et al. (2008) results in a monitoring regime aiming at obtaining information that provide certainty in proper treatment performance at minimal costs. In the context of this study and consistent with the AGWR, a surrogate is a quantifiable parameter that can serve as a performance measure of treatment processes that relate to removal of specific hazards. For example, conductivity is commonly used as a surrogate for the removal of chemical hazards by reverse osmosis. Similarly, an indicator chemical is a specific chemical that can be used to measure the efficacy of a treatment process. Chemical indicators are selected to represent characteristics of a family or group of chemicals, all of which are assumed to have comparable properties that determine their fate, transport, and removal during treatment.
Physicochemical properties (e.g., molecular size, pK a , log K ow , volatility, and dipole moment) often determine the fate and transport of a compound during various treatment processes such as high-pressure membranes (Bellona et al. 2004) .
Thus, the judicious selection of multiple indicators, representing a broad range of properties, enables the assessment to account for compounds that may not be currently identified (''unknowns''), as well as new compounds synthesised and entering the environment in the future (e.g., new pharmaceuticals), provided they fall within the range of the properties covered by the indicators. The underlying assumption is that absence or removal of an indicator compound during a treatment process would also ensure absence or removal of other compounds with comparable physicochemical properties. Proper removal is ensured as long as the treatment process of interest is operating according to its technical specifications. It is therefore necessary to define, for each treatment process, the operating conditions under which proper removal is to be expected ).
MONITORING PROGRAM
The advanced treatment train proposed for the RFP will utilise tertiary-treated wastewater (o6 mg/L total nitrogen) as source water and consist of chemical dosing (chloramination, pH adjustment), an integrated membrane system (IMS) consisting of ultrafiltration (UF) followed by reverse osmosis (RO) (ESPA2, Hydranautics, Oceanside, CA), a carbon dioxide scrubber and final chlorine disinfection and dechlorination. Of these unit processes, only RO will provide an effective treatment barrier for most chemical contaminants potentially present in the source water (Snyder et al. 2007 , Bellona et al. 2008 . Thus, the monitoring program developed in this study is designed to assure proper performance of the key treatment barrier, reverse osmosis, for these chemical contaminants.
According to the AGWR (2008), monitoring may be used to: obtain baseline information (to underpin the risk assessment process), determine whether recycled water systems will be safe and not represent a risk to human health or have detrimental effects on the environment (validation, i.e. 'Will it work?'), ensure that preventive measures are working (operational monitoring, i.e. 'Is it working now?'), determine whether the recycled water system has operated effectively, achieved compliance with management requirements and has not represented a risk to public health or had detrimental effects on the environment (verification, i.e. 'Did it work?'). Table 1 .
Piloting of the RO process at the proposed AWTP allowed both validating that operational parameters are within technical specifications and quantifying the removal (differential) of surrogate parameters (X i ) within these con-
In parallel, an occurrence study was undertaken to confirm the presence of viable indicator compounds in the final effluent of the three STPs (St Marys, Penrith and Quakers Hill) representing the source water feeding the AWTP. During piloting of the RO process, challenge tests were conducted with selected indicator compounds (Y i ) spiked at elevated concentrations to determine their removal differential DY i under normal operating conditions. The meaningful use of all of these measures requires that suitable process boundary conditions regarding Step 1 Define and verify operational boundary conditions for each unit process comprising the overall treatment train after operating the system assuring steady-state conditions. Do operational boundary conditions meet design criteria within an acceptable range?
Baseline Monitoring:
Conduct occurrence study to confirm presence of viable indicator compounds in the feedwater of each unit process If yes, proceed to step 2.
If not, determine cause for deviation.
Step 2 Quantify surrogate, e.g., conductivity rejection of overall system. Is conductivity rejection within previously observed range and does it meet performance specification of manufacturer?
Identify 5-10 suitable indicator compounds for spiking study (challenge test) at pilot-scale If yes, proceed to step 3
If not, determine cause for deviation, for example by quantifying conductivity rejection of individual pressure vessels
Step 3 Validation Monitoring: Validation Monitoring:
Quantify removal differential of viable surrogate parameter
Conduct spiking study with select indicator compounds (5-10) to determine the removal differentials under pre-determined operating conditions:
Step 4 Select viable surrogate and operational parameters for each unit process Select 3-6 indicator compounds from categories classified as ''Good removal''
Compliance Monitoring: Full-scale Operation
Step 5 Confirm operational boundary conditions of full-scale train and removal differential DX i for selected surrogate and operational parameters
Step 6 Operational Monitoring: Monitor differential DX i of select surrogate and operational parameters for each unit process or/and the overall treatment train on a regular basis (daily, weekly)
Verification Monitoring: Monitor differential DY i of selected indicator compounds for each unit process or/and the overall treatment train regularly, but less frequently (semi-annually, annually).
plant design and operation are maintained. For the proposed RO process, both at pilot-and full-scale, these boundary conditions were defined as a source water quality equivalent to UF-treated secondary effluent, pH adjusted to 6.3-6.7, addition of scale inhibitors, and operation at a recovery of 80 to 85%, and a permeate flux of approximately 20 L m À2 .h À1 .
Surrogate parameters
The removal of the surrogate parameter selected for perfor- Table 3 . In addition to these established indicator compounds, two further chemicals were tested. These were N-nitrosodiethylamine (NDEA) and N-nitrosodipropylamine Prior to and during the challenge tests, online pH, temperature, permeate flux, recovery and conductivity measurements were recorded. The challenge test was executed only after confirming that the system was achieving a conductivity rejection as previously observed during piloting and was operating within the above mentioned boundary conditions (recovery:~80%; permeate flux:~20 LMH; pH ¼ 6.5).
For each indicator compound, rejection was calculated (average concentration of combined permeate divided by average feed water concentration) and compared to the removal categories reported for indicator compounds for RO systems . Observed removal percentage similar or larger than the expected removal percentage 
Trimethoprim* Simvastatin hydroxy acid*1 di-Hydrotestosterone1 Bromodichloromethane1
Diclofenac*1 N-Nitrosodimethylamine**1 Bromochloromethane1
Fluoxetine* D Ibuprofen* D N-Nitrosodiethylamine1 Trischloroethylphosphate (TCEP)* D Naproxen* D Ketoprofen*1 N-Nitroso ethylmethylamine1 Bisphenol A* D *Potential suitable indicator compounds for RO processes identified by Drewes et al. (2008) and their degree of expected removal (*:490%; **:25-o50%) D Compounds detected in pilot plant influent at levels at least five times above the detection limit of usually 5 ng/L.
1Compounds detected in pilot plant influent, but at levels less than five times the detection limit. 
Monte-carlo analysis
In order to describe removal of contaminants by reverse Computing sums, multiplications and other transformations on multiple distribution functions is a mathematically challenging task and, in some cases, impossible. For this, Monte-Carlo techniques can provide a powerful alternative approach. Monte Carlo simulation is currently the most widely used method for probabilistic health risk assessment and exposure assessment (Paustenbach 2000; Lester et al. 2007 ).
Monte Carlo analysis was undertaken to simulate a distribution for percentage removal for each of the challenge test chemicals. The simulated removal distributions for three Nnitrosamines are provided in Figure 2 as illustrative examples.
These PDFs predicted mean removals for NDMA (32%), NDEA (91%) and NDPA (98%) resulting in concentrations consistently below 5 ng/L for these compounds in this pilot study. Of these, only NDMA was assessed by Drewes et al.
(2008) as a potential indicator compound with poor removal properties (25-50%). The PDF for NDMA in Figure 2 shows that most of the simulated distribution is indeed within this range. 9 Challenge test spiking protocol.
